Jeffrey A. S. Ritsema

Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats

Hessel van der Weide, Unai Cossío, Raquel Gracia et al. · Antimicrobial Agents and Chemotherapy · 2020 · 39 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Preparation, Characterization, and Biological Evaluation of a Hydrophilic Peptide Loaded on PEG-PLGA Nanoparticles

Lisa Marinelli, Michele Ciulla, Jeffrey A. S. Ritsema et al. · Pharmaceutics · 2022 · 34 citations · Full text

Pharmacy, Biotechnology, Pharmaceutics +17

Relationship between polarities of antibiotic and polymer matrix on nanoparticle formulations based on aliphatic polyesters

Jeffrey A. S. Ritsema, E.M.A. Herschberg, Sven Even Borgos et al. · International Journal of Pharmaceutics · 2017 · 32 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Iron nanomedicines induce Toll-like receptor activation, cytokine production and complement activation

J. Verhoef, Anne Marit de Groot, Marc van Moorsel et al. · Biomaterials · 2016 · 24 citations · Full text

Life Sciences, Immunology, Inflammation +14

Antibiotic-Nanomedicines: Facing the Challenge of Effective Treatment of Antibiotic-Resistant Respiratory Tract Infections

Jeffrey A. S. Ritsema, Hessel van der Weide, Yvonne M. te Welscher et al. · Future Microbiology · 2018 · 20 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutics +17